Dj%25252520citral

# Dj Citral (Dicyclomine/Citrate complex) ## Overview "Dj Citral" is not a standard pharmaceutical nomenclature. It is frequently conflated with **Dicyclomine** (an anticholinergic/antispasmodic) or proprietary formulations of **Citral** (often used as a flavoring or in homeopathic/naturopathic supplements). **If you are referring to Dicyclomine**, please see the clinical profile below. If this refers to a specific proprietary supplement, please verify the exact manufacturer components, as toxicity profiles vary significantly. ## Primary Indications Treatment of functional bowel/irritable bowel syndrome (IBS). ## Adult Dosing * **Initial:** 20 mg PO every 6 hours. * **Titration:** May increase to 40 mg PO every 6 hours if well-tolerated after one week. * **Maximum:** 160 mg per day. ## Pediatric Dosing * **Safety/Efficacy:** Not established in infants. Use is generally contraindicated in infants < 6 months due to risk of serious respiratory distress and seizures. * **Older children:** No standard pediatric dosing; use is typically off-label and requires specialist guidance based on local institutional protocols. ## Dose Adjustments * **Renal Impairment:** No specific guidelines; use with caution. * **Hepatic Impairment:** Use with caution. * **Geriatric:** Start at the lowest possible dose (10 mg) due to increased sensitivity to anticholinergic effects (Beers Criteria). ## Contraindications * Hypersensitivity to the drug. * Infants < 6 months. * Unstable cardiovascular status in acute hemorrhage. * Myasthenia gravis, glaucoma, obstructive uropathy, or severe ulcerative colitis. * Reflux esophagitis. ## Adverse Effects * **Common:** Dry mouth, dizziness, blurred vision, nausea, lightheadedness, and drowsiness. * **Serious:** Tachycardia, psychosis, confusion (especially in elderly), urinary retention, and paralytic ileus. ## Key Drug Interactions * **Anticholinergics:** Synergistic effects (additive toxicities). * **Digoxin:** Dicyclomine may increase serum digoxin levels by slowing GI motility. * **Antacids:** May interfere with absorption. ## Monitoring * Monitor for signs of anticholinergic toxicity (tachycardia, urinary retention, blurred vision, confusion). * Assess efficacy in symptom reduction for IBS; discontinue if no improvement after 2 weeks. ## Clinical Pearls * Dicyclomine is a potent antispasmodic but lacks the efficacy of specific IBS-directed therapies. * Avoid use in patients prone to heat prostration, as the drug suppresses sweating. * Counsel patients regarding sedation and impaired coordination; avoid driving/heavy machinery until effect is known. *** **Educational Disclaimer:** This information is for educational purposes only. Always verify current prescribing information, official package inserts, and local clinical protocols before administering any medication. Clinical judgment is required for individual patient care.